Pinned
🚨New Pub 🧵1) Our new study in #TranslationalLungCancerResearch explores a combination strategy for #KRASG12C-mutant #NSCLC: sotorasib plus trastuzumab deruxtecan. In preclinical models, the combination produced deeper and more durable regressions than either agent alone.












